Guillain–Barré syndrome

E196711

Guillain–Barré syndrome is an acute autoimmune disorder in which the immune system attacks peripheral nerves, leading to rapidly progressive muscle weakness and potential paralysis, often triggered by infections such as Campylobacter.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (5)

Statements (66)

Predicate Object
instanceOf acute inflammatory demyelinating polyradiculoneuropathy
autoimmune disease
neurological disorder
peripheral neuropathy
affectsSystem peripheral nervous system
canAffect children
hasCause autoimmune attack on peripheral nerves
hasClinicalCourse acute
monophasic
hasComplication chronic neuropathic pain
deep vein thrombosis
paralysis
pulmonary embolism
respiratory failure
hasDiagnosticFinding albuminocytologic dissociation in cerebrospinal fluid
hasDiagnosticTest electromyography
lumbar puncture
nerve conduction studies
hasIncidence about 1 to 2 cases per 100000 person-years
hasMortalityRate approximately 3–7 percent
hasOnsetPattern rapidly progressive
hasPathophysiology immune-mediated axonal damage
immune-mediated demyelination of peripheral nerves
hasPrimarySymptom areflexia
ascending muscle weakness
hyporeflexia
hasPrognosis most patients recover partially or completely
hasSexDistribution slightly more common in males
hasSubtype Guillain–Barré syndrome self-linksurface differs
surface form: Miller Fisher syndrome

Guillain–Barré syndrome self-linksurface differs
surface form: acute inflammatory demyelinating polyradiculoneuropathy

Guillain–Barré syndrome self-linksurface differs
surface form: acute motor and sensory axonal neuropathy

Guillain–Barré syndrome self-linksurface differs
surface form: acute motor axonal neuropathy
hasSymptom autonomic dysfunction
blood pressure instability
bulbar weakness
cardiac arrhythmia
facial weakness
gait disturbance
numbness in extremities
paresthesia
respiratory muscle weakness
hasSynonym GBS
acute inflammatory demyelinating polyneuropathy
hasTreatment intravenous immunoglobulin
mechanical ventilation
physical rehabilitation
plasma exchange
supportive care
thromboprophylaxis
hasTypicalAgeGroup adults
hasTypicalTrigger Campylobacter jejuni infection
Epstein–Barr virus infection
Mycoplasma pneumoniae infection
Zika virus infection
cytomegalovirus infection
gastrointestinal infection
infection
influenza infection
respiratory tract infection
surgery
vaccination
isClassifiedUnder immune-mediated neuropathies
rare diseases
wasFirstDescribedBy Georges Guillain
Jean Alexandre Barré
wasFirstDescribedInYear 1916

Referenced by (9)

Full triples — surface form annotated when it differs from this entity's canonical label.

Campylobacter complication Guillain–Barré syndrome
Janssen COVID-19 Vaccine rareAdverseEvents Guillain–Barré syndrome
2015–2016 Zika virus outbreak associatedWith Guillain–Barré syndrome
Guillain–Barré syndrome hasSubtype Guillain–Barré syndrome self-linksurface differs
this entity surface form: acute inflammatory demyelinating polyradiculoneuropathy
Guillain–Barré syndrome hasSubtype Guillain–Barré syndrome self-linksurface differs
this entity surface form: acute motor axonal neuropathy
Guillain–Barré syndrome hasSubtype Guillain–Barré syndrome self-linksurface differs
this entity surface form: acute motor and sensory axonal neuropathy
Guillain–Barré syndrome hasSubtype Guillain–Barré syndrome self-linksurface differs
this entity surface form: Miller Fisher syndrome
Ad26.COV2.S adverseEventOfSpecialInterest Guillain–Barré syndrome
Zika virus associatedCondition Guillain–Barré syndrome